3 hours Obesity Drugs-Tied ResMed Edges Higher On Quarterly BeatInvestor's Business Daily
ResMed stock rose Thursday after beating quarterly expectations, shrugging off worries that weight-loss drugs would hammer its topline.
The post Obesity Drugs-Tied ResMed Edges Higher On Quarterly Beat appeared first on Investor's Business Daily.